MEDLINE Journals

    Group A streptococcal infections.

    Authors

    Langlois DM, Andreae M 

    Institution

    Division of General Pediatrics, Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, MI, USA.

    Source

    Pediatr Rev 2011 Oct; 32(10) :423-9; quiz 430.

    Abstract

    • GAS is a common cause of upper respiratory tract and skin infections.• Based on strong research evidence, (1) throat culture is the gold standard for diagnosing GAS pharyngitis.• Based on strong research evidence, (1) oral penicillin V K is the antibiotic treatment of choice for GAS pharyngitis because of its efficacy, safety, and narrow spectrum.• Based on strong research evidence, (2) primary prevention of complications of GAS such as ARF involves prompt diagnosis and antibiotic treatment of GAS pharyngitis.• GAS nonsuppurative and suppurative complications may occur and are mediated by interactions between GAS antigens or exotoxins and the patient’s immunesystem.

    Mesh

    Anti-Bacterial Agents
    Child
    Fasciitis, Necrotizing
    Humans
    Pharyngitis
    Rheumatic Fever
    Shock, Septic
    Skin Diseases, Bacterial
    Streptococcal Infections
    Streptococcus pyogenes

    Language

    eng

    Pub Type(s)

    Journal Article

    PubMed ID

    21965709

    Content Manager
    Related Content

    Group A streptococcus.

    Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association.

    Group A streptococcal infections--1993.

    Group A streptococcal pharyngitis and immune-mediated complications: from diagnosis to management.

    Effectiveness of clinical guidelines for the presumptive treatment of streptococcal pharyngitis in Egyptian children.

    [Toxic shock-like syndrome caused by streptococci].

    Guidelines for sore throat management in New Zealand.

    Current issues in the prevention of rheumatic fever.